Alkermes plc (ALKS) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Alkermes plc Reports Second Quarter 2015 Financial Results
July 30, 2015 7:00 AM EDTSecond Quarter Revenues of $151.4 Million and Non-GAAP Diluted Loss Per Share of $0.09
Alkermes Unveils ARISTADA as Proposed Brand Name for Aripiprazole
Lauroxil;
Final Launch Preparations Underway in Advance of
Aug. 22, 2015 PDUFA Date
Company Improves Financial Expectations for 2015 Driven by Strong VIVITROL® Performance
DUBLIN--(BUSINESS WIRE)-- Alkermes plc... More
